PMC:7264098 / 1312-1588 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T30","span":{"begin":19,"end":34},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T31","span":{"begin":126,"end":130},"obj":"DG_47"},{"id":"T32","span":{"begin":152,"end":160},"obj":"SP_7"},{"id":"T33","span":{"begin":264,"end":272},"obj":"GO:0070062"},{"id":"T5958","span":{"begin":19,"end":34},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T35718","span":{"begin":126,"end":130},"obj":"DG_47"},{"id":"T92850","span":{"begin":152,"end":160},"obj":"SP_7"},{"id":"T19373","span":{"begin":264,"end":272},"obj":"GO:0070062"}],"text":"other investigated pharmacological treatments. There are currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with only one clinical trial testing MSC-derived exosomes via"}

{"project":"LitCovid-PubTator","denotations":[{"id":"30","span":{"begin":152,"end":160},"obj":"Disease"}],"attributes":[{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"other investigated pharmacological treatments. There are currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with only one clinical trial testing MSC-derived exosomes via"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T11","span":{"begin":152,"end":160},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"other investigated pharmacological treatments. There are currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with only one clinical trial testing MSC-derived exosomes via"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T16","span":{"begin":244,"end":251},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"other investigated pharmacological treatments. There are currently 17 clinical trials evaluating the therapeutic potential of MSCs for the treatment of COVID-19, the majority of which are administered intravenously with only one clinical trial testing MSC-derived exosomes via"}